WebNov 22, 2024 · The transaction was unanimously approved by the Dicerna Board of Directors and the Board of Directors of Novo Nordisk. Novo Nordisk and Dicerna have been parties to a research collaboration since 2024 to discover and develop RNAi therapies using Dicerna’s proprietary GalXC™ RNAi platform technology. The collaboration … WebFor its 2024 fiscal year, DICERNA PHARMACEUTICALS INC, listed the following executives on its annual proxy statement to the SEC. Equity. Cash Compensation. …
Dicerna™ Appoints Stephen Doberstein, Ph.D., to Board …
WebSep 23, 2024 · Hanover, MD (September 23, 2024) — Major, Lindsey & Africa (MLA), the world’s leading legal search firm, today announced the placement of Ling Zeng as chief legal officer and secretary at Dicerna Pharmaceuticals, Inc. in Lexington, Mass. The search was conducted by Ron Ciardiello and Nancy Reiner, both managing directors in MLA’s In … WebSep 19, 2024 · Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced the appointment of Patrick Gray to the Dicerna board of directors (the “board”) as an independent director, and the retirement of veteran director Dennis Langer, M.D., J.D. … notebook doodles unicorns
MLA Places Ling Zeng as Dicerna Pharmaceuticals’ Chief Legal …
WebAbout. Proven executive and leader with over 30 years of experience building life science companies and leading entrepreneurial teams to … WebHealthy mind and body. We believe progress starts with our people, so we’ll take good care of you. Working at Dicerna means access to such benefits as a competitive and comprehensive health plan, an education … WebType of white blood cell, or leukocyte, essential to the immune system. Intellia is engineering T cells against specific cancer antigens. receptors. Type of therapy where engineered cells are transferred into a patient’s body to grow, replace or repair damaged tissue, or perform another desired function. notebook download for pc